On this page
TYR
tyrosinase
TYR is located on the long (q) arm of chromosome 11, at band 11q14.3. Arm ratio per GRCh38 - banding schematic.
Explore chromosome 11 in the library →Available at Jeen Health
Clinical tests that include this
Overview
The TYR gene, located on chromosome 11, encodes tyrosinase, a copper-containing enzyme that catalyses the initial and rate-limiting step in melanin biosynthesis. Tyrosinase is expressed predominantly in melanocytes, specialised pigment-producing cells found in skin, hair follicles, the iris, and the retina. Melanin serves not only as a determinant of physical appearance but also plays crucial roles in photoprotection and visual development.
Pathogenic variants in TYR are inherited in an autosomal recessive pattern, meaning both gene copies must carry mutations for oculocutaneous albinism type 1 to manifest. This condition represents the most common form of albinism worldwide, with clinical severity ranging from complete absence of melanin production throughout life to milder forms with residual enzyme activity. Understanding TYR function is essential for carrier screening programmes aimed at identifying individuals at risk of transmitting albinism-related conditions to their children.
What the gene does
Tyrosinase functions as a monophenol monooxygenase, catalysing two sequential enzymatic reactions in the melanin synthesis pathway. The enzyme first hydroxylates the amino acid tyrosine to form L-3,4-dihydroxyphenylalanine (L-DOPA), then oxidises L-DOPA to dopaquinone. This dopaquinone intermediate undergoes further spontaneous and enzymatic transformations to generate eumelanin, the brown-black pigment, or pheomelanin, the red-yellow pigment, depending on the presence of cysteine and other cofactors.
The enzyme requires two copper ions bound at its active site for catalytic activity, and its function is tightly regulated within melanosomes, specialised organelles inside melanocytes where melanin synthesis occurs. Beyond pigmentation, tyrosinase activity in the retina contributes to normal visual development, as melanin in retinal pigment epithelium is necessary for proper photoreceptor alignment and light absorption. Disruption of tyrosinase function therefore affects not only external pigmentation but also the structural and functional integrity of the visual system, explaining the characteristic vision problems observed in oculocutaneous albinism.
Video: Genetics 101
Chromosome location
TYR is located on the long arm of chromosome 11 at cytogenetic band 11q14.3. The gene spans approximately 65 kilobases of genomic DNA and comprises five exons that encode a 529-amino acid protein. This chromosomal region has been well characterised, and the compact structure of TYR facilitates comprehensive genetic screening for pathogenic variants across all coding sequences and splice junctions in clinical diagnostic settings.
Protein structure
Tyrosinase is synthesised as a 529-amino acid polypeptide that undergoes post-translational modification and proteolytic processing within melanosomes. The mature enzyme contains a signal peptide directing it to the endoplasmic reticulum, followed by regions responsible for copper binding and catalytic activity. A disordered region spanning amino acids 287-313 is present within the protein structure, which may contribute to conformational flexibility important for substrate access or regulatory interactions. The copper-binding sites are critical for enzymatic function, and mutations affecting these domains typically abolish tyrosinase activity completely, resulting in the most severe albinism phenotypes.
Key variants
Over 100 pathogenic variants in TYR have been identified in individuals with oculocutaneous albinism type 1. The majority of these mutations result in complete loss of tyrosinase activity, preventing any melanin production throughout an affected individual's life. Missense variants, nonsense mutations, and small deletions or insertions are all represented in the variant spectrum. Some mutations retain partial enzyme function, correlating with milder phenotypes where small amounts of pigment accumulate over time. Carrier frequency varies across populations, with certain founder mutations enriched in specific ethnic groups.
Sample of pathogenic variants
10 pathogenic / likely-pathogenic variants from ClinVar, ranked by review status (expert-panel-reviewed first). This is a sample; recurrent founder variants in a specific population may not appear here - see the full ClinVar listing via the link above.
| Variant (HGVS) | Protein change | Classification | Evidence | Associated condition |
|---|---|---|---|---|
c.115T>C | p.Trp39Arg | Pathogenic | ★★☆☆ | Oculocutaneous albinism |
c.1169A>G | p.His390Arg | Pathogenic/Likely pathogenic | ★★☆☆ | Oculocutaneous albinism type 1 |
c.1177del | p.Val393fs | Pathogenic/Likely pathogenic | ★★☆☆ | TYR-related disorder |
c.1322C>A | p.Ser441Ter | Pathogenic/Likely pathogenic | ★★☆☆ | Oculocutaneous albinism type 1A |
c.272G>C | p.Cys91Ser | Pathogenic/Likely pathogenic | ★★☆☆ | Oculocutaneous albinism type 1 |
c.309C>A | p.Cys103Ter | Pathogenic/Likely pathogenic | ★★☆☆ | Oculocutaneous albinism type 1 |
c.696del | p.Ile233fs | Pathogenic/Likely pathogenic | ★★☆☆ | Oculocutaneous albinism type 1A |
c.746A>G | p.Asp249Gly | Pathogenic/Likely pathogenic | ★★☆☆ | Oculocutaneous albinism type 1A |
c.820-2A>G | - | Pathogenic/Likely pathogenic | ★★☆☆ | SKIN/HAIR/EYE PIGMENTATION 3, LIGHT/DARK SKIN |
c.838G>T | p.Glu280Ter | Pathogenic/Likely pathogenic | ★★☆☆ | Oculocutaneous albinism type 1 |
Evidence stars indicate ClinVar review status. Individual variant interpretation should always be performed by a qualified clinical laboratory - many variants remain classified as Variants of Uncertain Significance (VUS) pending more research.
Associated conditions
Pathogenic variants in TYR cause oculocutaneous albinism type 1, an autosomal recessive disorder characterised by absent or significantly reduced melanin in skin, hair, and eyes. Affected individuals typically present with white hair, very pale skin, and light-coloured irides from birth. Visual abnormalities include reduced visual acuity, nystagmus (involuntary eye movements), photophobia, and abnormal crossing of optic nerve fibres at the chiasm. The severity of oculocutaneous albinism type 1 varies depending on residual tyrosinase activity, with complete absence of function leading to the most pronounced phenotype and persistent lack of pigmentation across the lifespan.
Inheritance pattern
Conditions caused by pathogenic TYR variants typically follow autosomal recessive inheritance.
When both parents are carriers, each child has a 25% chance of being affected, 50% of being a carrier, and 25% of being unaffected.
UK clinical status
TYR is included on multiple NHS Genomic Medicine Service gene panels with green (high-evidence) ratings, reflecting its well-established role in inherited pigmentary and visual disorders. The gene appears on the Albinism or congenital nystagmus panel, the Ocular and oculo-cutaneous albinism panel, the Infantile nystagmus panel, and the Pigmentary skin disorders panel. It is also listed in the Developmental Disorders Genotype-to-Phenotype database (DDG2P), underscoring its clinical importance in diagnosing and managing conditions affecting pigmentation and vision within the NHS framework.
Sources: NHS GMS PanelApp · Genomics England PanelApp · NHS National Genomic Test Directory
Frequently asked questions
What does it mean to be a carrier of a TYR variant?
A carrier has one pathogenic TYR variant and one functional gene copy, which is sufficient for normal melanin production. Carriers typically have normal pigmentation and vision but can pass the variant to their children. If both parents are carriers, each pregnancy has a 25% chance of oculocutaneous albinism type 1.
How is oculocutaneous albinism type 1 managed?
Management focuses on protecting skin from ultraviolet exposure through sunscreen and protective clothing, and addressing visual problems with corrective lenses, low-vision aids, and educational support. Regular dermatological and ophthalmological monitoring is recommended to detect and manage complications such as photodamage or refractive errors.
Are all forms of albinism caused by TYR variants?
No, albinism is genetically heterogeneous. TYR variants cause oculocutaneous albinism type 1, but other genes such as OCA2, TYRP1, and SLC45A2 are responsible for different subtypes. Genetic testing can identify which gene is involved, which may inform prognosis and recurrence risk counselling.
References
- Murisier F, Beermann F. Genetics of pigment cells: lessons from the tyrosinase gene family. Histology and histopathology. 2006. PMID: 16493586
- Opitz S, Käsmann-Kellner B, Kaufmann M. Detection of 53 novel DNA variations within the tyrosinase gene and accumulation of mutations in 17 patients with albinism. Human mutation. 2004. PMID: 15146472
- Oetting WS, Fryer JP, Shriram S. Oculocutaneous albinism type 1: the last 100 years. Pigment cell research. 2003. PMID: 12753405
- King RA, Pietsch J, Fryer JP. Tyrosinase gene mutations in oculocutaneous albinism 1 (OCA1): definition of the phenotype. Human genetics. 2003. PMID: 13680365
- Oetting WS. The tyrosinase gene and oculocutaneous albinism type 1 (OCA1): A model for understanding the molecular biology of melanin formation. Pigment cell research. 2000. PMID: 11041207
- Adam MP, Bick S, Mirzaa GM. Oculocutaneous Albinism Type 1 – RETIRED CHAPTER, FOR HISTORICAL REFERENCE ONLY. 1993. PMID: 20301345